This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Poblotzki, A.
Right arrow Articles by Modrow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Poblotzki, A.
Right arrow Articles by Modrow, S.

 Previous Article  |  Next Article 

J. Virol., Oct 1996, 7327-7330, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Lymphoproliferative responses after infection with human parvovirus B19

A von Poblotzki, C Gerdes, U Reischl, H Wolf and S Modrow
Institut fur Medizinische Mikrobiologie und Hygiene der Universitat Regensburg, Germany.

Immunity after infection with the parvovirus B19 is assumed to be conferred by a humoral immune response with development of neutralizing antibody. In contrast, little is known about the nature of T-cell- mediated responses to parvovirus B19 infection in humans. We used recombinant proteins VP1, VP2, and NS1, as well as a recombinant VP1- specific amino-terminal sequence, to test the proliferative responses of peripheral blood mononuclear cells after infection of otherwise healthy individuals with parvovirus B19. These proteins were used as antigens for the stimulation of freshly isolated cells. The results show that a B19 virus-specific cellular immunity develops that is directed against the capsid proteins VP1 and VP2. We also demonstrate that viral determinants are presented to CD4+ T cells by HLA class II molecules.


This article has been cited by other articles:

  • Waldman, M., Kopp, J. B. (2007). Parvovirus B19 and the Kidney. CJASN 2: S47-S56 [Abstract] [Full Text]  
  • Kasprowicz, V., Isa, A., Tolfvenstam, T., Jeffery, K., Bowness, P., Klenerman, P. (2006). Tracking of Peptide-Specific CD4+ T-Cell Responses after an Acute Resolving Viral Infection: a Study of Parvovirus B19. J. Virol. 80: 11209-11217 [Abstract] [Full Text]  
  • Corcoran, A., Doyle, S. (2004). Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53: 459-475 [Abstract] [Full Text]  
  • Ball-Goodrich, L. J., Paturzo, F. X., Johnson, E. A., Steger, K., Jacoby, R. O. (2002). Immune Responses to the Major Capsid Protein during Parvovirus Infection of Rats. J. Virol. 76: 10044-10049 [Abstract] [Full Text]  
  • Heegaard, E. D., Brown, K. E. (2002). Human Parvovirus B19. Clin. Microbiol. Rev. 15: 485-505 [Abstract] [Full Text]  
  • Harder, T. C., Hufnagel, M., Zahn, K., Beutel, K., Schmitt, H.-J., Ullmann, U., Rautenberg, P. (2001). New LightCycler PCR for Rapid and Sensitive Quantification of Parvovirus B19 DNA Guides Therapeutic Decision-Making in Relapsing Infections. J. Clin. Microbiol. 39: 4413-4419 [Abstract] [Full Text]  
  • Kerr, J. R., Barah, F., Mattey, D. L., Laing, I., Hopkins, S. J., Hutchinson, I. V., Tyrrell, D. A. J. (2001). Circulating tumour necrosis factor-{alpha} and interferon-{gamma} are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J. Gen. Virol. 82: 3011-3019 [Abstract] [Full Text]  
  • MITCHELL, L. A., LEONG, R., ROSENKE, K. A. (2001). Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?. J Med Microbiol 50: 627-635 [Abstract] [Full Text]  
  • Jordan, J. A., Huff, D., DeLoia, J. A. (2001). Placental Cellular Immune Response in Women Infected with Human Parvovirus B19 during Pregnancy. CVI 8: 288-292 [Abstract] [Full Text]  
  • Tolfvenstam, T., Oxenius, A., Price, D. A., Shacklett, B. L., Spiegel, H. M. L., Hedman, K., Norbeck, O., Levi, M., Olsen, K., Kantzanou, M., Nixon, D. F., Broliden, K., Klenerman, P. (2001). Direct Ex Vivo Measurement of CD8+ T-Lymphocyte Responses to Human Parvovirus B19. J. Virol. 75: 540-543 [Abstract] [Full Text]  
  • Corcoran, A., Doyle, S., Waldron, D., Nicholson, A., Mahon, B. P. (2000). Impaired Gamma Interferon Responses against Parvovirus B19 by Recently Infected Children. J. Virol. 74: 9903-9910 [Abstract] [Full Text]  
  • Kerr, J. R (2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59: 672-683 [Full Text]